ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS
Clinical trials for ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS explained in plain language.
Never miss a new study
Get alerted when new ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS trials appear
Sign up with your email to follow new studies for ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One-Shot cell therapy tested for devastating autoimmune diseases
Disease control OngoingThis is an early safety study testing a single dose of an experimental cell therapy called SC291. It is for adults with severe forms of lupus or a blood vessel disease called ANCA-associated vasculitis that have not improved with at least two prior treatments. The goal is to see …
Matched conditions: ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS
Phase: PHASE1 • Sponsor: Sana Biotechnology • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New drug trial targets root cause of multiple serious kidney diseases
Disease control OngoingThis study is testing a new drug called povetacicept in adults with several serious autoimmune kidney diseases, including lupus nephritis and IgA nephropathy. The main goals are to see if the drug is safe and if it can help control these diseases. Participants receive injections …
Matched conditions: ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS
Phase: PHASE1, PHASE2 • Sponsor: Alpine Immune Sciences, Inc. • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Doctors test if risky drugs can be safely stopped for kidney failure patients
Disease control OngoingThis study aims to find out if it's safe to stop long-term immune-suppressing drugs in patients with ANCA vasculitis who have developed total kidney failure. Researchers will compare patients who stop the drugs to those who continue them, checking for severe infections, disease f…
Matched conditions: ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS
Phase: PHASE3 • Sponsor: Centre Hospitalier Departemental Vendee • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC